Label change for testosterone: Implications for urologists, prescribers, and patients
Gene therapy shows encouraging efficacy for overactive bladder
Baseline 68Ga-PSMA-11 PET/CT parameters can predict response to 177Lu-PSMA-617
Genetic test can predict risk of toxicity following radiation for prostate cancer
